- Home
- CADL vs BGH Comparison
CADL vs BGH Comparison
Compare CADL & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.35
Company Overview
Basic Information| Metric | CADL | BGH |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 297.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CADL | BGH |
|---|---|---|
| Price | $6.35 | $15.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 936.0K | 61.5K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $11.92 |
| 52 Week High | $13.68 | $14.50 |
Technical Indicators
Market Signals| Indicator | CADL | BGH |
|---|---|---|
| Relative Strength Index (RSI) | 72.12 | 45.08 |
| Support Level | $5.39 | $15.05 |
| Resistance Level | $6.83 | $15.22 |
| Average True Range (ATR) | 0.36 | 0.12 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 80.81 | 46.67 |
Price Performance
Historical Comparison CADL
BGH
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.